CareDx (NASDAQ: CDNA) reported Q2 EPS of ($0.04), $0.03 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $17.8 million versus the consensus estimate of $15.49 million.

Guidance:

For the full year 2018, CareDx expects revenue to be in the range of $68 million to $70 million (previously $64 million to $66 million), with adjusted EBITDA profitability expected during the current half of the year

For earnings history and earnings-related data on CareDx (CDNA) click here.